BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...

SAN FRANCISCO -- Candidates for an implantable cardioverter-defibrillator (ICD) found that a subcutaneous device dramatically slashed the major lead-related complications seen with transvenous devices ...

If you have hypertrophic cardiomyopathy (HCM), and especially if you have obstructive HCM that reduces blood flow out of your heart, you and your doctor may discuss ways to lower your risk of sudden ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

Cleveland Clinic doctors were the first in the world to successfully implant leadless pacemaker defibrillator systems in two patients as part of a global clinical trial sponsored by Boston Scientific, ...

Implantation of an S-ICD in a Patient with a DDD Pacemaker and Congenitally Corrected Transposition of the Great Arteries In a new publication from Cardiovascular ...

Our original January 27 article, “Subcutaneous Solar Cells Could Power Pacemakers,” described a real-life study that looked at the potential of powering medical implants with solar cells. The study ...

Subcutaneous implantable cardioverter-defibrillator (S-ICD) therapies represent a significant advance in the prevention of sudden cardiac death. By positioning both the generator and the lead entirely ...

The Cleveland Clinic announced their team successfully implanted the world's first leadless pacemaker defibrillator system in two patients. Pacemakers provide electrical stimulation to regulate a ...

As part of a global clinical trial, Cleveland Clinic has successfully implanted a leadless pacemaker defibrillator system in the world's first two patients, according to a news release. The novel ...